Horoquartz has been acquired by Amano
The shareholders of Horoquartz have sold the company to Japan-based Amano for US$73 million. The deal involved 100% cash at completion.
Horoquartz is a market leader in time and scheduling software solutions, offering companies and public organizations agile tools necessary to facilitate the relationship between the employer and its employees.
Amano offers a diverse range of solutions for the effective use of human resources, from the basic time recorders to the latest network attendance management systems. Amano will support Horoquartz's expansion in Europe taking advantage of the technology in Japan.
Oaklins' team in France advised the seller in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
Niscon Inc. has been acquired by SGPS ShowRig
Niscon Inc. has been successfully acquired by SGPS ShowRig, a global provider of staging, rigging and automation for live entertainment. The acquisition reinforces SGPS Showrig’s commitment to pushing the boundaries of innovation in the entertainment industry. By adding Niscon’s unique motion-control technology to its portfolio, SGPS Showrig strengthens its ability to deliver cutting-edge, precision-driven solutions.
Lär dig merFairfest Media has acquired WTE Miami
Fairfest Media, organizer of OTM, the leading travel show in Asia, has acquired WTE Miami, the fastest-growing travel trade show in the USA. The acquisition marks a significant milestone in Fairfest’s global expansion, strengthening its presence in the Americas and beyond by leveraging decades of experience and leadership in Asia and India.
Lär dig merBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Lär dig mer